A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma (Q40622703)
Jump to navigation
Jump to search
scientific article published on April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma |
scientific article published on April 2000 |
Statements
1 reference
A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma (English)
1 reference
Vitetta ES
1 reference
Jaffe ES
1 reference
Ghetie V
1 reference
Messmann RA
1 reference
Headlee D
1 reference
Senderowicz AM
1 reference
Figg WD
1 reference
Schindler J
1 reference
Michiel DF
1 reference
Creekmore S
1 reference
Steinberg SM
1 reference
Kohler D
1 reference
Stetler-Stevenson M
1 reference
Chen H
1 reference
Sausville EA
1 reference
1 April 2000
1 reference
1 reference
6
1 reference
4
1 reference
1302-1313
1 reference
Identifiers
1 reference